All-trans retinoic acid recalibrates macrophage transcriptional responses to drug-resistant Mycobacterium tuberculosis through strain-specific immunometabolic reprogramming
This study demonstrates that while all-trans retinoic acid (ATRA) can recalibrate macrophage immunometabolic responses to drug-susceptible and multidrug-resistant *Mycobacterium tuberculosis* by promoting resolution signaling and preserving antimicrobial pathways, its efficacy is significantly attenuated in extensively drug-resistant strains due to unique immune evasion mechanisms and transcriptional refractoriness.